Technical Analysis for GBS - GBS Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Up |
| Historical GBS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Hot IPO Pullback | Bullish Swing Setup | 3.77% | |
| Narrow Range Bar | Range Contraction | 3.77% | |
| Narrow Range Bar | Range Contraction | 6.87% | |
| NR7 | Range Contraction | 6.87% | |
| Inside Day | Range Contraction | 6.87% | |
| Hot IPO Pullback | Bullish Swing Setup | 10.89% | |
| NR7 | Range Contraction | 10.89% | |
| Down 3 Days in a Row | Weakness | 10.89% | |
| Hot IPO Pullback | Bullish Swing Setup | 10.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Possible Pocket Pivot | 2 days ago | |
| Hot IPO Pullback Entry | 2 days ago | |
| Rose Above Previous Day's High | 2 days ago | |
| 2x Volume Pace | 2 days ago | |
| 1.5x Volume Pace | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It operates in Mainland China, Hong Kong, Vietnam, and Bangladesh. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Diabetes Tumor Glucose Diagnostic Tests Biomarkers Blood Glucose Monitoring Monitoring Diabetes Management Chemical Pathology Biosensor
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Diabetes Tumor Glucose Diagnostic Tests Biomarkers Blood Glucose Monitoring Monitoring Diabetes Management Chemical Pathology Biosensor
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.2399 |
| 52 Week Low | 7.03 |
| Average Volume | 483,530 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 7.74 |
| Average True Range | 1.26 |
| ADX | 0.0 |
| +DI | 10.81 |
| -DI | 15.64 |
| Chandelier Exit (Long, 3 ATRs ) | 10.45 |
| Chandelier Exit (Short, 3 ATRs ) | 10.82 |
| Upper Bollinger Band | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | -0.12 |
| MACD Signal Line | -0.07 |
| MACD Histogram | -0.0414 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.56 | ||||
| Resistance 3 (R3) | 9.53 | 9.06 | 9.34 | ||
| Resistance 2 (R2) | 9.06 | 8.73 | 9.08 | 9.27 | |
| Resistance 1 (R1) | 8.65 | 8.52 | 8.86 | 8.69 | 9.20 |
| Pivot Point | 8.19 | 8.19 | 8.29 | 8.20 | 8.19 |
| Support 1 (S1) | 7.78 | 7.85 | 7.98 | 7.81 | 7.30 |
| Support 2 (S2) | 7.31 | 7.65 | 7.33 | 7.23 | |
| Support 3 (S3) | 6.91 | 7.31 | 7.16 | ||
| Support 4 (S4) | 6.94 |
